Dichloroacetate Overcomes Oxaliplatin Chemoresistance in Colorectal Cancer through the miR-543/PTEN/Akt/mTOR Pathway

Chemoresistance is responsible for most colorectal cancer (CRC) related deaths. In this study, we found that dichloroacetate (DCA), a pyruvate dehydrogenase kinase (PDK) inhibitor, can be used as a sensitizer for oxaliplatin (L-OHP) chemoresistant CRC cells. The aim of this study was to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yu, Zhu, Danxi, Zhu, Liming, Hou, Yichao, Hou, Lidan, Huang, Xin, Li, Linjing, Wang, Yu, Li, Lei, Zou, Huimin, Wu, Tianqi, Yao, Mengfei, Wang, Jianhua, Meng, Xiangjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856576/
https://www.ncbi.nlm.nih.gov/pubmed/31762813
http://dx.doi.org/10.7150/jca.34650

Ejemplares similares

Ejemplares similares